Robaxin Injection
Product Images NDC 0641-6103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Robaxin (NDC 0641-6103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Robaxin 1)

Chemical structure diagram depicting the molecular composition of methocarbamol, the active ingredient in ROBAXIN injection 100 mg/mL by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Unit Label (Robaxin 2)

Robaxin Injection (Methocarbamol Injection, USP) 100 mg/mL, a 10 mL single-dose vial for intramuscular or intravenous injection. The label includes dosage concentration of 1,000 mg per 10 mL and is manufactured by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Additional instructions on storage and usage are partially visible.*

FDA Label Image

Carton Label (Robaxin 3)

Robaxin Injection (methocarbamol) 100 mg/mL injection vial label for intravenous or intramuscular use. The label states the concentration as 1,000 mg per 10 mL (100 mg/mL) and that the packaging contains 10 single dose vials. Manufactured by Hikma Pharmaceuticals USA Inc. Instructions for storage and usage conditions are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.